What's happening to Buffett's Tech investment, IBM?! Check out our Report to see our take on its valuation! HIDE

Orexigen Therapeutics (OREX)

Add to Watchlists
Create an Alert
4.39 +0.01  +0.23% NASDAQ Oct 24, 12:13PM BATS Real time Currency in USD

Orexigen Therapeutics Enterprise Value:

485.33M for Oct. 23, 2014

View 4,000+ financial data types

View Full Chart

Orexigen Therapeutics Enterprise Value Chart

Export Data
Save Image

Orexigen Therapeutics Historical Enterprise Value Data

View and export this data going back to 2007. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Oct. 23, 2014 485.33M
Oct. 22, 2014 477.98M
Oct. 21, 2014 501.26M
Oct. 20, 2014 446.12M
Oct. 17, 2014 448.57M
Oct. 16, 2014 462.05M
Oct. 15, 2014 436.32M
Oct. 14, 2014 372.60M
Oct. 13, 2014 349.32M
Oct. 10, 2014 368.92M
Oct. 9, 2014 386.08M
Oct. 8, 2014 398.33M
Oct. 7, 2014 403.23M
Oct. 6, 2014 424.06M
Oct. 3, 2014 444.89M
Oct. 2, 2014 443.67M
Oct. 1, 2014 443.67M
Sept. 30, 2014 470.63M
Sept. 29, 2014 502.48M
Sept. 26, 2014 503.71M
Sept. 25, 2014 506.16M
Sept. 24, 2014 512.29M
Sept. 23, 2014 519.64M
Sept. 22, 2014 501.26M
Sept. 19, 2014 533.12M
Sept. 18, 2014 547.82M
Sept. 17, 2014 556.40M
Sept. 16, 2014 534.34M
Sept. 15, 2014 546.60M
Sept. 12, 2014 580.91M
Sept. 11, 2014 595.61M
Sept. 10, 2014 671.58M
Sept. 9, 2014 665.46M
Sept. 8, 2014 694.86M
Sept. 5, 2014 683.84M
Sept. 4, 2014 682.61M
Sept. 3, 2014 660.55M
Sept. 2, 2014 649.53M
Aug. 29, 2014 647.08M
Aug. 28, 2014 650.75M
Aug. 27, 2014 672.81M
Aug. 26, 2014 670.36M
Aug. 25, 2014 642.17M
Aug. 22, 2014 650.75M
Aug. 21, 2014 644.62M
Aug. 20, 2014 655.65M
Aug. 19, 2014 661.78M
Aug. 18, 2014 633.60M
Aug. 15, 2014 631.15M
Aug. 14, 2014 658.10M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for

OREX Enterprise Value Benchmarks

Vivus 244.42M
Arena Pharmaceuticals 754.04M
Takeda Pharmaceutical 34.69B

OREX Enterprise Value Range, Past 5 Years

Minimum -45.25M Jan 3 2012
Maximum 745.15M Mar 18 2014
Average 288.18M

OREX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("OREX", "enterprise_value")
  • Last 5 data points: =YCS("OREX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.